Literature DB >> 8642289

Cytokine imbalance and autoantibody production in T cell receptor-alpha mutant mice with inflammatory bowel disease.

A Mizoguchi1, E Mizoguchi, C Chiba, G M Spiekermann, S Tonegawa, C Nagler-Anderson, A K Bhan.   

Abstract

Spontaneous inflammatory bowel disease (IBD) resembling human ulcerative colitis develops in mice mutant for the T cell receptor alpha gene (TCR-alpha-/-). TCR-alpha-/- mice lack TCR-alpha/beta+ cells but contain TCR-gamma/delta+ cells and a small population of a unique CD4+, TCR-alpha-/beta+(low) cells. Since all the immunoglobulin (Ig) classes are present in these mice, help to B cells must be provided by cells other than TCR-alpha/beta+ cells. In the present study, we found serum levels of IgG1 and IgG2 to be markedly increased in TCR-alpha-/- mice with IBD as compared to TCR-alpha-/- mice without IBD or TCR-alpha+/- controls. An increase in IgG1-, IgG2a- and IgA- but not IgM-secreting mesenteric lymph node (MLN) B cells was detected in TCR-alpha-/- mutant mice. There was also a marked increase in MLN B cells secreting autoantibody (IgG) to tropomyosin, a cytoskeletal protein. Examination of the hyperplastic MLN showed a marked increase in the number of B, TCR-delta+, and CD4+ TCR-alpha-/beta+ cells, similar to the cell population observed at the site of colonic inflammation. Analysis of spontaneous cytokine production by MLN cells using an enzyme-linked immunospot assay, immunohistochemistry, and reverse transcription/polymerase chain reaction showed a decrease of interleukin 2 (IL-2) but a marked increase of IL-4 and interferon gamma (IFN-gamma) production in TCR-alpha-/- mice with IBD as compared to TCR-alpha-/- mice without IBD and TCR alpha+/- control mice. Both TCR-alpha-/beta+ and TCR-delta+ cells were found to be capable of producing IL-4; IFN-gamma was produced mostly by non-T cells, many of which were shown to be CD3- NK 1.1+ cells. We propose that the cytokine imbalance present in these mice results in expansion of B cells, production and switching of autoantibodies to IgG2 subclass, and development of IBD. It is possible that the unusual CD4+ TCR-alpha-/beta+ population and expanded TCR-gamma/delta+ population present in TCR-alpha-/- mice plays a central role in this abnormal immune response.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8642289      PMCID: PMC2192355          DOI: 10.1084/jem.183.3.847

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  35 in total

1.  Antiproliferative effect of IFN-gamma in immune regulation. III. Differential selection of TH1 and TH2 murine helper T lymphocyte clones using recombinant IL-2 and recombinant IFN-gamma.

Authors:  T F Gajewski; J Joyce; F W Fitch
Journal:  J Immunol       Date:  1989-07-01       Impact factor: 5.422

Review 2.  TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties.

Authors:  T R Mosmann; R L Coffman
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

3.  An improvement of the single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  C Puissant; L M Houdebine
Journal:  Biotechniques       Date:  1990-02       Impact factor: 1.993

4.  A novel two colour ELISPOT assay. I. Simultaneous detection of distinct types of antibody-secreting cells.

Authors:  C Czerkinsky; Z Moldoveanu; J Mestecky; L A Nilsson; O Ouchterlony
Journal:  J Immunol Methods       Date:  1988-11-25       Impact factor: 2.303

5.  Regulation of B lymphocytes by natural killer cells. Role of IFN-gamma.

Authors:  A Michael; J J Hackett; M Bennett; V Kumar; D Yuan
Journal:  J Immunol       Date:  1989-02-15       Impact factor: 5.422

6.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

7.  Message amplification phenotyping (MAPPing): a technique to simultaneously measure multiple mRNAs from small numbers of cells.

Authors:  C A Brenner; A W Tam; P A Nelson; E G Engleman; N Suzuki; K E Fry; J W Larrick
Journal:  Biotechniques       Date:  1989 Nov-Dec       Impact factor: 1.993

8.  Tropomyosin shares immunologic epitopes with group A streptococcal M proteins.

Authors:  P G Fenderson; V A Fischetti; M W Cunningham
Journal:  J Immunol       Date:  1989-04-01       Impact factor: 5.422

9.  Isolation and characterization of a colonic autoantigen specifically recognized by colon tissue-bound immunoglobulin G from idiopathic ulcerative colitis.

Authors:  F Takahashi; K M Das
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

10.  Characterization of immature thymocyte lines derived from T-cell receptor or recombination activating gene 1 and p53 double mutant mice.

Authors:  P Mombaerts; C Terhorst; T Jacks; S Tonegawa; J Sancho
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-01       Impact factor: 11.205

View more
  61 in total

Review 1.  Cytokines in experimental colitis.

Authors:  P Garside
Journal:  Clin Exp Immunol       Date:  1999-12       Impact factor: 4.330

2.  Th1-type responses mediate spontaneous ileitis in a novel murine model of Crohn's disease.

Authors:  M M Kosiewicz; C C Nast; A Krishnan; J Rivera-Nieves; C A Moskaluk; S Matsumoto; K Kozaiwa; F Cominelli
Journal:  J Clin Invest       Date:  2001-03       Impact factor: 14.808

Review 3.  Serologic testing in inflammatory bowel disease: its value in indeterminate colitis.

Authors:  K A Papadakis; S R Targan
Journal:  Curr Gastroenterol Rep       Date:  1999-12

4.  T regulatory cells maintain intestinal homeostasis by suppressing γδ T cells.

Authors:  Sung-Gyoo Park; Ramkumar Mathur; Meixiao Long; Namiko Hosh; Liming Hao; Matthew S Hayden; Sankar Ghosh
Journal:  Immunity       Date:  2010-11-11       Impact factor: 31.745

5.  Oral immune regulation using colitis extracted proteins for treatment of Crohn's disease: results of a phase I clinical trial.

Authors:  Eran Israeli; Eran Goldin; Oren Shibolet; Athalia Klein; Nilla Hemed; Dean Engelhardt; Elazar Rabbani; Yaron Ilan
Journal:  World J Gastroenterol       Date:  2005-05-28       Impact factor: 5.742

6.  Thymus leukemia antigen controls intraepithelial lymphocyte function and inflammatory bowel disease.

Authors:  Danyvid Olivares-Villagómez; Yanice V Mendez-Fernandez; Vrajesh V Parekh; Saif Lalani; Tiffaney L Vincent; Hilde Cheroutre; Luc Van Kaer
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-12       Impact factor: 11.205

Review 7.  Roles of galectins in inflammatory bowel disease.

Authors:  Akira Hokama; Emiko Mizoguchi; Atsushi Mizoguchi
Journal:  World J Gastroenterol       Date:  2008-09-07       Impact factor: 5.742

8.  Exploring the interplay of barrier function and leukocyte recruitment in intestinal inflammation by targeting fucosyltransferase VII and trefoil factor 3.

Authors:  P L Beck; E Ihara; S A Hirota; J A MacDonald; D Meng; N N Nanthakumar; D K Podolsky; R J Xavier
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-03-18       Impact factor: 4.052

Review 9.  Relationship of extraintestinal involvements in inflammatory bowel disease: new insights into autoimmune pathogenesis.

Authors:  K M Das
Journal:  Dig Dis Sci       Date:  1999-01       Impact factor: 3.199

10.  Lymphocyte-dependent and Th2 cytokine-associated colitis in mice deficient in Wiskott-Aldrich syndrome protein.

Authors:  Deanna D Nguyen; Michel H Maillard; Vinicius Cotta-de-Almeida; Emiko Mizoguchi; Christoph Klein; Ivan Fuss; Cathryn Nagler; Atsushi Mizoguchi; Atul K Bhan; Scott B Snapper
Journal:  Gastroenterology       Date:  2007-07-12       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.